2,242
Views
45
CrossRef citations to date
0
Altmetric
Research Paper

Effects of cannabinoid receptor type 2 in respiratory syncytial virus infection in human subjects and mice

, , , , , , , , , , & show all
Pages 217-230 | Received 12 Jun 2017, Accepted 04 Oct 2017, Published online: 08 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alireza Tahamtan, Masoumeh Tavakoli-Yaraki & Vahid Salimi. (2020) Opioids/cannabinoids as a potential therapeutic approach in COVID-19 patients. Expert Review of Respiratory Medicine 14:10, pages 965-967.
Read now
Alireza Tahamtan, Saeed Samadizadeh, Mostafa Rastegar, Britt Nakstad & Vahid Salimi. (2020) Respiratory syncytial virus infection: why does disease severity vary among individuals?. Expert Review of Respiratory Medicine 14:4, pages 415-423.
Read now

Articles from other publishers (43)

Hayder M. Al-Kuraishy, Ali I. Al-Gareeb, Athanasios Alexiou & Gaber El-Saber Batiha. (2023) Cannabinoids Receptors in COVID-19: Perpetrators and Victims. Current Medicinal Chemistry 30:34, pages 3832-3845.
Crossref
Florian BrandesAnnekathrin M. KeilerBenedikt KirchnerMelanie BorrmannJean-Noël Billaud, Marlene ReithmairMatthias KleinPatrizia Campolongo, Detlef ThiemeMichael W. PfafflGustav Schelling & Agnes S. Meidert. (2023) Extracellular Vesicles and Endocannabinoid Signaling in Patients with COVID-19. Cannabis and Cannabinoid Research.
Crossref
Arnaud John Kombe Kombe & Tengchuan Jin. (2023) Editorial: Host-microbe interaction in SARS-CoV-2 infection: mechanism and intervention. Frontiers in Immunology 14.
Crossref
Oksana Yu. Kytikova, Yulia K. Denisenko, Tatyana P. Novgorodtseva & Ivan S. Kovalenko. (2023) Cannabinoids And Cannabinoid-Like Compounds: Biochemical Characterization And Pharmacological Perspectives. Russian Open Medical Journal 12:1.
Crossref
Beatrice Marchetti, Sabrine Bilel, Micaela Tirri, Raffaella Arfè, Giorgia Corli, Elisa Roda, Carlo Alessandro Locatelli, Elena Cavarretta, Fabio De Giorgio & Matteo Marti. (2023) The Old and the New: Cardiovascular and Respiratory Alterations Induced by Acute JWH-018 Administration Compared to Δ9-THC—A Preclinical Study in Mice. International Journal of Molecular Sciences 24:2, pages 1631.
Crossref
Fatemeh Hosami, Vahid Salimi, Banafsheh Safizadeh, Atefeh Abedini, Maryam Haghparast Ghadimkhah & Masoumeh Tavakoli-Yaraki. (2022) Evaluation of the local and circulating expression level of cannabinoid receptor 2 in patients with lung cancer. Gene Reports 29, pages 101671.
Crossref
Jincheng Chen, Fuxiang Wang, Su Zhang, Qiao Lin, Hui Xu, Tengfei Zhu, Ling Peng, Fulan Cen, Fang Li, Zhaoqin Wang, Carl G. Feng, Zhinan Yin, Yingxia Liu & Guoliang Zhang. (2022) Activation of CD4+ T Cell–Derived Cannabinoid Receptor 2 Signaling Exacerbates Sepsis via Inhibiting IL-10. The Journal of Immunology 208:11, pages 2515-2522.
Crossref
Fatemeh Aghamahdi, Arman Shafiee, Sayeh Rostami, Zakiye Mokhames, Mahshid Safavi, Somayeh Yaslianifard, Zeinab Siami, Kourosh Kabir, Gholamreza Azizi, Mahmood Bakhtiyari & Sayed-Hamidreza Mozhgani. (2022) Comparative study of CNR1 and CNR2 cannabinoid receptors expression levels in COVID-19 patients with and without diabetes mellitus: Recommendations for future research targets. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16:5, pages 102499.
Crossref
Saeed Samadizadeh, Mehdi Sheikh Arabi, Mohammad Yasaghi, Vahid Salimi, Alijan Tabarraei, Abdolvahab Moradi & Alireza Tahamtan. (2022) Anti-inflammatory effects of curcumin-loaded niosomes on respiratory syncytial virus infection in a mice model. Journal of Medical Microbiology 71:4.
Crossref
Marcin Janecki, Michał Graczyk, Agata Anna Lewandowska & Łukasz Pawlak. (2022) Anti-Inflammatory and Antiviral Effects of Cannabinoids in Inhibiting and Preventing SARS-CoV-2 Infection. International Journal of Molecular Sciences 23:8, pages 4170.
Crossref
Susana Santos, Pedro Barata, Adilia Charmier, Inês Lehmann, Suzilaine Rodrigues, Matteo M. Melosini, Patrick J. Pais, André P. Sousa, Catarina Teixeira, Inês Santos, Ana Catarina Rocha, Pilar Baylina & Ruben Fernandes. (2022) Cannabidiol and Terpene Formulation Reducing SARS-CoV-2 Infectivity Tackling a Therapeutic Strategy. Frontiers in Immunology 13.
Crossref
Fatemeh Hosami, Azadeh Manayi, Vahid Salimi, Farshad Khodakhah, Mitra Nourbakhsh, Britt Nakstad & Masoumeh Tavakoli-Yaraki. (2021) The pro-apoptosis effects of Echinacea purpurea and Cannabis sativa extracts in human lung cancer cells through caspase-dependent pathway. BMC Complementary Medicine and Therapies 21:1.
Crossref
Fatemeh Hosami, Maryam Haghparast Ghadimkhah, Vahid Salimi, Seyedeh Sara Ghorbanhosseini & Masoumeh Tavakoli-Yaraki. (2021) The strengths and limits of cannabinoids and their receptors in cancer: Insights into the role of tumorigenesis-underlying mechanisms and therapeutic aspects. Biomedicine & Pharmacotherapy 144, pages 112279.
Crossref
Aleksandra Kicman, Anna Pędzińska-Betiuk & Hanna Kozłowska. (2021) The potential of cannabinoids and inhibitors of endocannabinoid degradation in respiratory diseases. European Journal of Pharmacology 911, pages 174560.
Crossref
Mostafa Rastegar, Saeed Samadizadeh, Mohammad Yasaghi, Abdolvahab Moradi, Alijan Tabarraei, Vahid Salimi & Alireza Tahamtan. (2021) Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: a human study and molecular docking. Archives of Virology 166:11, pages 3117-3126.
Crossref
Niraj Kumar Jha, Charu Sharma, Mohamed Fizur Nagoor Meeran, Saurabh Kumar Jha, Vivek Dhar Dwivedi, Piyush Kumar Gupta, Abhijit Dey, Kavindra Kumar Kesari & Shreesh Ojha. (2021) Cannabinoid Type-2 Receptor Agonist, JWH133 May Be a Possible Candidate for Targeting Infection, Inflammation, and Immunity in COVID-19. Immuno 1:3, pages 285-304.
Crossref
Liwen Zhang, Yu Wan, Liang Ma, Kaihong Xu & Baojin Cheng. (2021) Inhibition of NF-κB/IL-33/ST2 Axis Ameliorates Acute Bronchiolitis Induced by Respiratory Syncytial Virus. Journal of Immunology Research 2021, pages 1-11.
Crossref
Hebaallah Mamdouh Hashiesh, Charu Sharma, Sameer N. Goyal, Niraj Kumar Jha & Shreesh Ojha. (2021) Pharmacological Properties, Therapeutic Potential and Molecular Mechanisms of JWH133, a CB2 Receptor-Selective Agonist. Frontiers in Pharmacology 12.
Crossref
Michał Graczyk, Agata Anna Lewandowska & Tomasz Dzierżanowski. (2021) The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation. Molecules 26:15, pages 4551.
Crossref
Farshad Khodakhah, Alireza Tahamtan, Mona Marzban, Azadeh Shadab, Masoumeh Tavakoli-Yaraki, Seyed Mahmoud Hashemi, Talat Mokhatri-Azad, Britt Nakstad & Vahid Salimi. (2021) Hyperglycemia results in decreased immune cell infiltration and increased viral load in the lung in a mouse model of RSV infection. Cytokine 143, pages 155539.
Crossref
Cristian Scheau, Constantin Caruntu, Ioana Anca Badarau, Andreea-Elena Scheau, Anca Oana Docea, Daniela Calina & Ana Caruntu. (2021) Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier. Journal of Personalized Medicine 11:6, pages 494.
Crossref
Niraj Kumar Jha, Charu Sharma, Hebaallah Mamdouh Hashiesh, Seenipandi Arunachalam, MF Nagoor Meeran, Hayate Javed, Chandragouda R. Patil, Sameer N. Goyal & Shreesh Ojha. (2021) β-Caryophyllene, A Natural Dietary CB2 Receptor Selective Cannabinoid can be a Candidate to Target the Trinity of Infection, Immunity, and Inflammation in COVID-19. Frontiers in Pharmacology 12.
Crossref
Pasin Hemachudha & Thiravat Hemachudha. (2021) Rabies: Presentation, case management and therapy. Journal of the Neurological Sciences 424, pages 117413.
Crossref
Estefanía Moreno, Milena Cavic & Enric I. Canela. (2021) Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System—Implications for Health and Disease. International Journal of Molecular Sciences 22:7, pages 3661.
Crossref
M.F. Nagoor Meeran, Hayate Javed, Charu Sharma, Sameer N. Goyal, Sanjay Kumar, Niraj Kumar Jha & Shreesh Ojha. (2021) Can Echinacea be a potential candidate to target immunity, inflammation, and infection - The trinity of coronavirus disease 2019. Heliyon 7:2, pages e05990.
Crossref
M. F. Nagoor Meeran, Charu Sharma, Sameer N. Goyal, Sanjay Kumar & Shreesh Ojha. (2020) CB2 receptor‐selective agonists as candidates for targeting infection, inflammation, and immunity in SARS‐CoV ‐2 infections . Drug Development Research 82:1, pages 7-11.
Crossref
Norbert E. Kaminski & Barbara L.F. Kaplan. 2021. Advances in Immunopharmacology. Advances in Immunopharmacology 1 59 .
Paweł Śledziński, Agnieszka Nowak-Terpiłowska & Joanna Zeyland. (2020) Cannabinoids in Medicine: Cancer, Immunity, and Microbial Diseases. International Journal of Molecular Sciences 22:1, pages 263.
Crossref
Trina Ekawati Tallei, Sefren Geiner Tumilaar, Nurdjannah Jane Niode, Fatimawali, Billy Johnson Kepel, Rinaldi Idroes, Yunus Effendi, Shahenur Alam Sakib & Talha Bin Emran. (2020) Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (Mpro) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study. Scientifica 2020, pages 1-18.
Crossref
Myriam El Biali, Barbara Broers, Marie Besson & Jules Demeules. (2020) Cannabinoids and COVID-19. Medical Cannabis and Cannabinoids 3:2, pages 111-115.
Crossref
Steven D. Pan, Denis Grandgirard & Stephen L. Leib. (2020) Adjuvant Cannabinoid Receptor Type 2 Agonist Modulates the Polarization of Microglia Towards a Non-Inflammatory Phenotype in Experimental Pneumococcal Meningitis. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Somayeh Shatizadeh Malekshahi, Yazdan Samieipour, Ali Akbar Rahbarimanesh, Anahita Izadi, Nastaran Ghavami, Shaghayegh Razaghipour, Maryam Naseri, Talat Mokhtari-Azad & Vahid Salimi. (2020) Genetic characterization of G protein in respiratory syncytial virus ON-1 genotype in Tehran. Future Virology 15:11, pages 725-734.
Crossref
Deniz Öner, Simon B Drysdale, Calum McPherson, Gu-Lung Lin, Sophie Janet, Jonathan Broad, Andrew J Pollard, Jeroen Aerssens, Harish Nair, Harry Campbell, Peter Openshaw, Philippe Beutels, Louis Bont, Andrew Pollard, Eva Molero, Federico Martinon-Torres, Terho Heikkinen, Adam Meijer, Thea Kølsen Fischer, Maarten van den Berge, Carlo Giaquinto, Clarisse Demont, Scott Gallichan, Philip Dormitzer, Amanda Leach, Laura Dillon, Jeroen Aerssens, Brian Rosen, Harish Nair, Harry Campbell, Peter Openshaw, Philippe Beutels, Louis Bont, Andrew Pollard, Eva Molero, Federico Martinon-Torres, Terho Heikkinen, Adam Meijer, Thea Kølsen Fischer, Maarten van den Berge, Carlo Giaquinto, Clarisse Demont, Scott Gallichan, Philip Dormitzer, Amanda Leach, Laura Dillon, Jeroen Aerssens & Brian Rosen. (2020) Biomarkers for Disease Severity in Children Infected With Respiratory Syncytial Virus: A Systematic Literature Review. The Journal of Infectious Diseases 222:Supplement_7, pages S648-S657.
Crossref
Cherifa Beji, Hamza Loucif, Roman Telittchenko, David Olagnier, Xavier Dagenais-Lussier & Julien van Grevenynghe. (2020) Cannabinoid-Induced Immunomodulation during Viral Infections: A Focus on Mitochondria. Viruses 12:8, pages 875.
Crossref
Osnat Almogi-Hazan & Reuven Or. (2020) Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back. International Journal of Molecular Sciences 21:12, pages 4448.
Crossref
Francesca Rossi, Chiara Tortora, Maura Argenziano, Alessandra Di Paola & Francesca Punzo. (2020) Cannabinoid Receptor Type 2: A Possible Target in SARS-CoV-2 (CoV-19) Infection?. International Journal of Molecular Sciences 21:11, pages 3809.
Crossref
Alireza Tahamtan, Shahrzad Rezaiy, Saeed Samadizadeh, Abdolvahab Moradi, Alijan Tabarraei, Naeme Javid, Morteza Oladnabi & Mohammad Hosein Naeimi. (2019) Cannabinoid CB2 Receptor Functional Variation (Q63R) Is Associated with Multiple Sclerosis in Iranian Subjects. Journal of Molecular Neuroscience 70:1, pages 26-31.
Crossref
Turgut Emrah Bozkurt. (2019) Endocannabinoid System in the Airways. Molecules 24:24, pages 4626.
Crossref
Somayeh Shatizadeh Malekshahi, Shaghayegh Razaghipour, Yazdan Samieipoor, Farhad B. Hashemi, Ali Akbar Rahbari Manesh, Anahita Izadi, Ebrahim Faghihloo, Nastaran Ghavami, Talat Mokhtari-Azad & Vahid Salimi. (2019) Molecular characterization of the glycoprotein and fusion protein in human respiratory syncytial virus subgroup A: Emergence of ON-1 genotype in Iran. Infection, Genetics and Evolution 71, pages 166-178.
Crossref
Alireza Tahamtan, Fatemeh Sana Askari, Louis Bont & Vahid Salimi. (2019) Disease severity in respiratory syncytial virus infection: Role of host genetic variation. Reviews in Medical Virology 29:2.
Crossref
Sima Binaafar, Majid Kalani, Fatemeh Nayeri, Shiva Irani, Vahid Salimi, Mamak Shariat, Nikoo Niknafs, Hosein Dalili, Elaheh Amini, Tahereh Esmaeilnia Shirvani, Amir-Kamal Hardani, Roya Taheritafti, Nasrin Ghasemi-Fakhr, Mohsen Ghadami, Javad Tavakkoly-Bazzaz & Ali Rashidi-Nezhad. (2018) Evaluation of the Potential Association Between Cannabinoid Receptor 2 Gene Q63R Polymorphism (Rs35761398) and Risk of RDS Development in Preterm Neonates. Iranian Journal of Pediatrics In Press:In Press.
Crossref
Alireza TahamtanMasoumeh Tavakoli-YarakiAzadeh ShadabFarhad RezaeiSayed Mahdi MarashiFazel ShokriTalat Mokhatri-AzadVahid Salimi. (2018) The Role of Cannabinoid Receptor 1 in the Immunopathology of Respiratory Syncytial Virus. Viral Immunology 31:4, pages 292-298.
Crossref
Vahid Salimi, Habib Mirzaei, Ali Ramezani, Alireza Tahamtan, Abbas Jamali, Shahram Shahabi, Maryam Golaram, Bagher Minaei, Mohammad Javad Gharagozlou, Mahmood Mahmoodi, Louis Bont, Fazel Shokri & Talat Mokhtari-Azad. (2017) Blocking of opioid receptors in experimental formaline-inactivated respiratory syncytial virus (FI-RSV) immunopathogenesis: from beneficial to harmful impacts. Medical Microbiology and Immunology 207:2, pages 105-115.
Crossref